Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Nektar Therapeutics (NASDAQ:NKTR – Free Report) by 5.6% in the third quarter, according to the company in its most … [+3622 chars]

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)

Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)
Connor Clark & Lunn Investment Management Ltd. Acquires 34,599 Shares of Nektar Therapeutics (NASDAQ:NKTR)
Ads Links by Easy Branches
Play online games for free at games.easybranches.com
Guest Post Services www.easybranches.com/contribute
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007
Lin BioScience Receives U.S. FDA Fast Track Designation For LBS-007

Idorsia enters into exclusive negotiations for global rights to aprocitentan
Dr. Reddy's launches Toripalimab in India, the first and only immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma